{"id":"NCT00396292","sponsor":"American Regent, Inc.","briefTitle":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia","officialTitle":"Comparison of the Safety and Efficacy of Intravenous Iron vs Oral Iron in Subjects Who Display Postpartum Anemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-02","primaryCompletion":"2005-11","completion":"2006-02","firstPosted":"2006-11-06","resultsPosted":"2013-12-10","lastUpdate":"2018-02-05"},"enrollment":361,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"Oral iron tablets","otherNames":["Ferrous Sulfate"]},{"type":"DRUG","name":"VIT-45","otherNames":[]}],"arms":[{"label":"VIT-45","type":"EXPERIMENTAL"},{"label":"Oral iron tablets","type":"ACTIVE_COMPARATOR"}],"summary":"This study compares the safety and efficacy of intravenous iron vs oral iron in subjects who display postpartum anemia.","primaryOutcome":{"measure":"Number of Subjects Who Achieved 'Success' Meaning a â‰¥ 2.0 Increase in Hemoglobin","timeFrame":"anytime between baseline and the end of study or time to intervention","effectByArm":[{"arm":"VIT-45","deltaMin":162,"sd":null},{"arm":"Oral Iron Tablets","deltaMin":159,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["17666600"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":174},"commonTop":["Headache","Constipation","Nausea"]}}